BRIEF-Neurosense Therapeutics Ltd - Resuming Regulatory Advancement In Canada For Primec In Amyotrophic Lateral Sclerosis
Reuters
Dec 04, 2025
BRIEF-Neurosense Therapeutics Ltd - Resuming Regulatory Advancement In Canada For Primec In Amyotrophic Lateral Sclerosis
Dec 4 (Reuters) - Neurosense Therapeutics Ltd NRSN.O:
NEUROSENSE THERAPEUTICS LTD - RESUMING REGULATORY ADVANCEMENT IN CANADA FOR PRIMEC IN AMYOTROPHIC LATERAL SCLEROSIS
NEUROSENSE THERAPEUTICS LTD - ANTICIPATES POTENTIAL NDS SUBMISSION BY MID-2026
Source text: [ID:n0001213900-25-118083]
Further company coverage: NRSN.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.